medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-07-36-38medsovet-1249Research ArticleЗДОРОВЫЙ РЕБЕНОКHEALTHY CHILDВакцинопрофилактика ротавирусной инфекцииRotavirus vaccinationТаточенкоВ. К.TatochenkoV. K.

д.м.н., профессор

MD, Prof.

Федеральное государственное автономное учреждение Научный центр здоровья детей Российской академии медицинских наук, МоскваРоссияScientific Center of Children’s Health, MoscowRussian Federation201630122016073638Copyright © Таточенко В.К., 20162016Таточенко В.К.Tatochenko V.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1249

Ротавирусная (РВ) инфекция (РВИ), вызывающая острый гастроэнтерит (РВГЭ), относится к числу наиболее распространенных инфекционных заболеваний у детей как в развивающихся, так и в развитых странах. До открытия РВ заболевание обозначали как «токсическая диспепсия», «наша холера» – «cholera nostra». По данным ВОЗ, в 2008 г. в мире РВ унес 453 тыс. детских жизней, в основном в развивающихся странах, показатель смертности от РВГЭ – 80 на 100 тыс. Ежегодно с РВГЭ госпитализируется не менее 2 млн детей; по данным из 35 стран, РВ обусловливает 40% (34–45%) всех диарей [1].

Rotavirus (RV) infection (RVI) which causes acute gastroenteritis (RVGE) is among the most common infectious diseases in children in both developing and developed countries. Before the name RV was invented, the disease was designated as “toxic dyspepsia”, “our cholera” - “cholera nostra”. According to the WHO, in 2008 RV caused 453 thousand children’s deaths worldwide, mostly in the developing countries; RV mortality is 80 per 100 thousand. Annually, at least 2 million children are admitted to hospitals with RVGE; according to data from 35 countries, RV causes 40% (34–45%) of all diarrhea [1].

детиротавирусная инфекциявакцинацияРотаТек.childrenrotavirus infectionvaccinationRotaTeqReferencesWHO position paper January 2013 – Rotavirus vaccines. Weekly epid. Rec., 2013, 88(5): 49-64.WHO position paper January 2013 – Rotavirus vaccines. Weekly epid. Rec., 2013, 88(5): 49-64.Soriano-Gabarro M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatric Infectious Disease Journal, 2006, 25(1): S7-11.Soriano-Gabarro M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatric Infectious Disease Journal, 2006, 25(1): S7-11.Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and Severe Childhood Diarrhea. Emerg Infect Dis., 2006, 12: 304-306.Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and Severe Childhood Diarrhea. Emerg Infect Dis., 2006, 12: 304-306.Подколзин А.Т., Мухина А.А., Шипулин Г.А. и др. Изучение этиологии острых кишечных инфекций у детей, госпитализированных в инфекционные отделения стационаров Москвы. Инфекционные болезни, 2004, 2(4): 85-91.Подколзин А.Т., Мухина А.А., Шипулин Г.А. и др. Изучение этиологии острых кишечных инфекций у детей, госпитализированных в инфекционные отделения стационаров Москвы. Инфекционные болезни, 2004, 2(4): 85-91.Fruhwirth M, Heininger U, Ehlken B et al. International variation in disease burden of rotavirus gastroenteritis in children with communityand nosocomiallly acquired infection. Pediatric Infectious Disease Journal, 2001, 20: 784-791.Fruhwirth M, Heininger U, Ehlken B et al. International variation in disease burden of rotavirus gastroenteritis in children with communityand nosocomiallly acquired infection. Pediatric Infectious Disease Journal, 2001, 20: 784-791.Oh DY, Gaedicke G, Schreier E. Viral agents of acute gastroenteritis in German children: prevalence and molecular diversity. J Med Virol., 2003, 71: 82-93.Oh DY, Gaedicke G, Schreier E. Viral agents of acute gastroenteritis in German children: prevalence and molecular diversity. J Med Virol., 2003, 71: 82-93.Таточенко В.К., Озерецковский Н.А., Федоров А.М. Иммунопрофилактика, 2014. М.: Педиатръ, 2014.Таточенко В.К., Озерецковский Н.А., Федоров А.М. Иммунопрофилактика, 2014. М.: Педиатръ, 2014.Podkolzin EB, Fenske N, Abramycheva Yu. Hospital-Based surveillance of rotavirus and other viral agents of diarrhea in children and adults in Russia, 2005–2007. J Infect Dis, 2009, 200: S228-33.Podkolzin EB, Fenske N, Abramycheva Yu. Hospital-Based surveillance of rotavirus and other viral agents of diarrhea in children and adults in Russia, 2005–2007. J Infect Dis, 2009, 200: S228-33.Gleizes O, Desselberger U, Tatochenko V et. al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J., 2006 Jan, 25(1 Suppl): S12-21.Gleizes O, Desselberger U, Tatochenko V et. al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J., 2006 Jan, 25(1 Suppl): S12-21.Евро-Азиатское общество по инфекционным болезням, межрегиональная общественная организация «Ассоциация Врачей». Клинические рекомендации (протокол лечения) оказания медицинской помощи детям больным ротавирусной инфекцией. СПб., 2014.Евро-Азиатское общество по инфекционным болезням, межрегиональная общественная организация «Ассоциация Врачей». Клинические рекомендации (протокол лечения) оказания медицинской помощи детям больным ротавирусной инфекцией. СПб., 2014.Foppa IM, Karmaus W, Ehlken B et al. Health care-associated rotavirus illness in pediatric inpatients in Germany, Austria, and Switzerland. Infect Control Hosp Epidemiol, 2006, 27: 633-5.Foppa IM, Karmaus W, Ehlken B et al. Health care-associated rotavirus illness in pediatric inpatients in Germany, Austria, and Switzerland. Infect Control Hosp Epidemiol, 2006, 27: 633-5.The rational use of drugs in the management of acute diarrhea in children. World Health Organization, 1990.The rational use of drugs in the management of acute diarrhea in children. World Health Organization, 1990.Грекова А.И., Жаркова Л.П. Выбор антибактериальной терапии острых кишечных инфекций у детей (Результаты многоцентрового аналитического исследования). Педиатр. фармакол., 2007, 4(4):16-19.Грекова А.И., Жаркова Л.П. Выбор антибактериальной терапии острых кишечных инфекций у детей (Результаты многоцентрового аналитического исследования). Педиатр. фармакол., 2007, 4(4):16-19.Oldak E, Rozkiewicz D, Sulik A, Pogorzelska E, Al-Hwish MA. Antibiotic use for acute gastroenteritis in ambulatory care of children before and after implementation the healthcare system reform in Poland. Pol Merkur Lekarski, 2006, 20(116): 155-158.Oldak E, Rozkiewicz D, Sulik A, Pogorzelska E, Al-Hwish MA. Antibiotic use for acute gastroenteritis in ambulatory care of children before and after implementation the healthcare system reform in Poland. Pol Merkur Lekarski, 2006, 20(116): 155-158.Guarino A, Ashkenaz S, Gendrel D et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014. JPGN, 2014, 59 (1): 132-152.Guarino A, Ashkenaz S, Gendrel D et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014. JPGN, 2014, 59 (1): 132-152.Velázquez FR, Matson DO, Calva JJ et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med, 1996 Oct 3, 335(14): 1022-8.Velázquez FR, Matson DO, Calva JJ et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med, 1996 Oct 3, 335(14): 1022-8.Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human- bovine (WC3) reassortant rotavirus vaccine. N Engl J Med, 2006 Jan 5, 354(1): 23-33.Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human- bovine (WC3) reassortant rotavirus vaccine. N Engl J Med, 2006 Jan 5, 354(1): 23-33.Tate JE, Panozzo CA, Payne DC, Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics, 2009 Aug, 124(2): 465-71.Tate JE, Panozzo CA, Payne DC, Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics, 2009 Aug, 124(2): 465-71.Topachevskyi O, Van Effelterre T, Standaert B. ЕSPID 31, Milano, 2013, #848.Topachevskyi O, Van Effelterre T, Standaert B. ЕSPID 31, Milano, 2013, #848.Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalizations in South Australian children following the introduction of rotavirus vaccination. Vaccine, 2011 Jun 24, 29(29-30): 4663-7.Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalizations in South Australian children following the introduction of rotavirus vaccination. Vaccine, 2011 Jun 24, 29(29-30): 4663-7.Vesikari T, Van Damme P, Giaquinto C et al. European Society for Paediatric Infectious Diseases Consensus Recommendations for Rotavirus Vaccination in Europe. Update 2014. Pediatri Infect Dis J, 2015, 34(6): 635-643.Vesikari T, Van Damme P, Giaquinto C et al. European Society for Paediatric Infectious Diseases Consensus Recommendations for Rotavirus Vaccination in Europe. Update 2014. Pediatri Infect Dis J, 2015, 34(6): 635-643.Vesikari T. Rotavirus vaccination: a concise review. Clinical Microbiology and Infection, 2012, 18(Supplement 5): 54-63.Vesikari T. Rotavirus vaccination: a concise review. Clinical Microbiology and Infection, 2012, 18(Supplement 5): 54-63.

The authors declare that there are no conflicts of interest present.